chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: a little tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (a little tiredness) in a 120-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced FATIGUE (a little tiredness). On 10-Feb-2021, FATIGUE (a little tiredness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Upon in internal review on 21 May 2021, the age was corrected to an unknown age.   This case was linked to MOD-2021-075139 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Influenza like illness, Muscle spasms
Clinical narrative: Flu like symptoms; Cramping; Hair is falling out; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramping), ALOPECIA (Hair is falling out) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramping), ALOPECIA (Hair is falling out) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE SPASMS (Cramping), ALOPECIA (Hair is falling out) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: symptom of more nauseous feeling; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (symptom of more nauseous feeling) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included PRAVASTATIN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced NAUSEA (symptom of more nauseous feeling). At the time of the report, NAUSEA (symptom of more nauseous feeling) outcome was unknown. Not Provided          Concomitant products included Acid reflux medication for an unknown indication. No treatment information was reported. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Musculoskeletal stiffness
Clinical narrative: stiff neck; Very bad headache; Joint aches, especially in neck and shoulder; feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck), HEADACHE (Very bad headache), ARTHRALGIA (Joint aches, especially in neck and shoulder) and FATIGUE (feeling very tired) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 07-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck), HEADACHE (Very bad headache), ARTHRALGIA (Joint aches, especially in neck and shoulder) and FATIGUE (feeling very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck), HEADACHE (Very bad headache), ARTHRALGIA (Joint aches, especially in neck and shoulder) and FATIGUE (feeling very tired) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-074787 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074787:Wife case
Sex: M
Vaccine: COVID19
Symptoms: Headache, Lethargy, Vomiting
Clinical narrative: only wants to stay in bed and sleep; headache; vomited; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (only wants to stay in bed and sleep), HEADACHE (headache) and VOMITING (vomited) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced LETHARGY (only wants to stay in bed and sleep), HEADACHE (headache) and VOMITING (vomited). At the time of the report, LETHARGY (only wants to stay in bed and sleep), HEADACHE (headache) and VOMITING (vomited) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Joint swelling, Myalgia
Clinical narrative: knees joint swollen; really bad muscle pain in her leg; really affecting her work and her energy; Pain is so bad; more fatigue than usual; knees joint sore; normal aches; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (knees joint swollen), PAIN IN EXTREMITY (really bad muscle pain in her leg), ASTHENIA (really affecting her work and her energy), PAIN (Pain is so bad) and MYALGIA (normal aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M2CA and 041120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Acupuncture (3 times).   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (normal aches). On an unknown date, the patient experienced JOINT SWELLING (knees joint swollen), PAIN IN EXTREMITY (really bad muscle pain in her leg), ASTHENIA (really affecting her work and her energy), PAIN (Pain is so bad), FATIGUE (more fatigue than usual) and ARTHRALGIA (knees joint sore). The patient was treated with IBUPROFEN for Pain, at a dose of over last 2 weeks is taking more ibuprofen. At the time of the report, JOINT SWELLING (knees joint swollen), PAIN IN EXTREMITY (really bad muscle pain in her leg), ASTHENIA (really affecting her work and her energy), PAIN (Pain is so bad), MYALGIA (normal aches), FATIGUE (more fatigue than usual) and ARTHRALGIA (knees joint sore) had not resolved.            Concomitant medication included cholesterol medicines.   Patient primary care physician told her didn't think this could be a side effects of the vaccine, but she states never ever had this thing before.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: knees joint swollen; really bad muscle pain in her leg; really affecting her work and her energy; Pain is so bad; more fatigue than usual; knees joint sore; normal aches; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (knees joint swollen), PAIN IN EXTREMITY (really bad muscle pain in her leg), ASTHENIA (really affecting her work and her energy), PAIN (Pain is so bad) and MYALGIA (normal aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M2CA and 041120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Acupuncture (3 times).   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (normal aches). On an unknown date, the patient experienced JOINT SWELLING (knees joint swollen), PAIN IN EXTREMITY (really bad muscle pain in her leg), ASTHENIA (really affecting her work and her energy), PAIN (Pain is so bad), FATIGUE (more fatigue than usual) and ARTHRALGIA (knees joint sore). The patient was treated with IBUPROFEN for Pain, at a dose of over last 2 weeks is taking more ibuprofen. At the time of the report, JOINT SWELLING (knees joint swollen), PAIN IN EXTREMITY (really bad muscle pain in her leg), ASTHENIA (really affecting her work and her energy), PAIN (Pain is so bad), MYALGIA (normal aches), FATIGUE (more fatigue than usual) and ARTHRALGIA (knees joint sore) had not resolved.            Concomitant medication included cholesterol medicines.   Patient primary care physician told her didn't think this could be a side effects of the vaccine, but she states never ever had this thing before.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: had a bad reaction to the vaccine severe allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (had a bad reaction to the vaccine severe allergic reaction) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERSENSITIVITY (had a bad reaction to the vaccine severe allergic reaction). At the time of the report, HYPERSENSITIVITY (had a bad reaction to the vaccine severe allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: it is warm to touch.; very itchy and comes and goes; Rsh at the injection site which spread to her entire upper arm; pink to red area on upper arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (it is warm to touch.), RASH PRURITIC (very itchy and comes and goes), VACCINATION SITE RASH (Rsh at the injection site which spread to her entire upper arm) and VACCINATION SITE ERYTHEMA (pink to red area on upper arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE WARMTH (it is warm to touch.), RASH PRURITIC (very itchy and comes and goes), VACCINATION SITE RASH (Rsh at the injection site which spread to her entire upper arm) and VACCINATION SITE ERYTHEMA (pink to red area on upper arm). The patient was treated with CORTISONE ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (it is warm to touch.), RASH PRURITIC (very itchy and comes and goes), VACCINATION SITE RASH (Rsh at the injection site which spread to her entire upper arm) and VACCINATION SITE ERYTHEMA (pink to red area on upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient tried cool compress which helped. Treatment included Benadryl and used a topical cortisone cream per doctor recommendation.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Heart rate
Clinical narrative: shortness of breath; cough; extreme fatigue; fever; chills; nausea; fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath), COUGH (cough), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 120-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue). On 12-Mar-2021, the patient experienced DYSPNOEA (shortness of breath), COUGH (cough) and FATIGUE (extreme fatigue). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency and LEVOFLOXACIN at an unspecified dose and frequency. On 11-Mar-2021, PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue) had resolved. At the time of the report, DYSPNOEA (shortness of breath), COUGH (cough) and FATIGUE (extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Heart rate: increased (High) Increased heart rate. On 12-Mar-2021, Oxygen saturation: low (Low) oxygen low.         No concomitant information was reported. Treatment medication included 2 rounds of ABTs,  OTC cough medicine, Advil nose spray.  Patient reported that she visited to health clinic on 31 Mar 2021 and emergency department on 05 Ape 2021 for her symptoms. She also reported that she had all test  were negative included flu test and 2 Covid 19 tests. She reported that all test were normal other than a virus detected, however it was not specified by her.  Upon in internal review on 21 May 2021, the age was corrected to an unknown age.   This case was linked to MOD-2021-075130.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oxygen saturation, Pyrexia
Clinical narrative: shortness of breath; cough; extreme fatigue; fever; chills; nausea; fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (shortness of breath), COUGH (cough), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 120-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue). On 12-Mar-2021, the patient experienced DYSPNOEA (shortness of breath), COUGH (cough) and FATIGUE (extreme fatigue). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency and LEVOFLOXACIN at an unspecified dose and frequency. On 11-Mar-2021, PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and FATIGUE (fatigue) had resolved. At the time of the report, DYSPNOEA (shortness of breath), COUGH (cough) and FATIGUE (extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Heart rate: increased (High) Increased heart rate. On 12-Mar-2021, Oxygen saturation: low (Low) oxygen low.         No concomitant information was reported. Treatment medication included 2 rounds of ABTs,  OTC cough medicine, Advil nose spray.  Patient reported that she visited to health clinic on 31 Mar 2021 and emergency department on 05 Ape 2021 for her symptoms. She also reported that she had all test  were negative included flu test and 2 Covid 19 tests. She reported that all test were normal other than a virus detected, however it was not specified by her.  Upon in internal review on 21 May 2021, the age was corrected to an unknown age.   This case was linked to MOD-2021-075130.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Rash
Clinical narrative: Rash; Tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash), FATIGUE (Tired) and HEADACHE (Headache) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash), FATIGUE (Tired) and HEADACHE (Headache). At the time of the report, RASH (Rash), FATIGUE (Tired) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash, Rash pruritic, Skin warm
Clinical narrative: Redness on her arm; Rash is itching; Rash is really warm; A rash on her arm the rash was not on her skin it was under it and pink; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Redness on her arm), RASH PRURITIC (Rash is itching), SKIN WARM (Rash is really warm) and RASH (A rash on her arm the rash was not on her skin it was under it and pink) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fracture (fracture in her back).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced ERYTHEMA (Redness on her arm), RASH PRURITIC (Rash is itching), SKIN WARM (Rash is really warm) and RASH (A rash on her arm the rash was not on her skin it was under it and pink). At the time of the report, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Redness on her arm), RASH PRURITIC (Rash is itching), SKIN WARM (Rash is really warm) and RASH (A rash on her arm the rash was not on her skin it was under it and pink) outcome was unknown. Not Provided          Concomitant medication included muscle relaxer and pain medication to get over back fracture. Patient used ice pack to treat her symptoms. Patient felt ill hence she delayed her 2nd shot.   This case was linked to MOD-2021-075125 (E2B Linked Report). This case was linked to MOD-2021-075125 (Patient Link).; Sender's Comments:  MOD-2021-075125:1st dose of vaccine
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: joints ached; exhausted; was tired the day of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (was tired the day of the vaccine), ARTHRALGIA (joints ached) and FATIGUE (exhausted) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (was tired the day of the vaccine). On 11-Mar-2021, the patient experienced ARTHRALGIA (joints ached) and FATIGUE (exhausted). At the time of the report, FATIGUE (was tired the day of the vaccine) and FATIGUE (exhausted) outcome was unknown and ARTHRALGIA (joints ached) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant information was reported.  No treatment information was reported.   This case was linked to MOD-2021-075161 (Patient Link).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fall, Headache, Myalgia, Nausea
Clinical narrative: his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day; dizziness; fell back into bed; achiness/sore; Headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day), DIZZINESS (dizziness), FALL (fell back into bed), MYALGIA (achiness/sore) and HEADACHE (Headache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Tinnitus (had a previous diagnosis of tinnitus and also states he wears a hearing aid in his right ear).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced TINNITUS (his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day), DIZZINESS (dizziness), FALL (fell back into bed), MYALGIA (achiness/sore), HEADACHE (Headache) and NAUSEA (nausea). At the time of the report, TINNITUS (his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day), DIZZINESS (dizziness), FALL (fell back into bed), MYALGIA (achiness/sore), HEADACHE (Headache) and NAUSEA (nausea) outcome was unknown.            No concomitant medications were provided  No treatment medications were provided   This case was linked to MOD-2021-074093 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Action taken was updated.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day; dizziness; fell back into bed; achiness/sore; Headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day), DIZZINESS (dizziness), FALL (fell back into bed), MYALGIA (achiness/sore) and HEADACHE (Headache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Tinnitus (had a previous diagnosis of tinnitus and also states he wears a hearing aid in his right ear).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced TINNITUS (his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day), DIZZINESS (dizziness), FALL (fell back into bed), MYALGIA (achiness/sore), HEADACHE (Headache) and NAUSEA (nausea). At the time of the report, TINNITUS (his tinnitus jumped to a 6-8/frequency would fluctuate "fizzle and crack" depending on time of the day), DIZZINESS (dizziness), FALL (fell back into bed), MYALGIA (achiness/sore), HEADACHE (Headache) and NAUSEA (nausea) outcome was unknown.            No concomitant medications were provided  No treatment medications were provided   This case was linked to MOD-2021-074093 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Action taken was updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Fever of 101; Achey all over; Swollen lymph node; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101), MYALGIA (Achey all over) and LYMPHADENOPATHY (Swollen lymph node) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036821A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included CITALOPRAM, PRAVASTATIN, IBUPROFEN and VERAPAMIL for an unknown indication.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced PYREXIA (Fever of 101), MYALGIA (Achey all over) and LYMPHADENOPATHY (Swollen lymph node). At the time of the report, PYREXIA (Fever of 101) and MYALGIA (Achey all over) had resolved and LYMPHADENOPATHY (Swollen lymph node) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, Body temperature: 101 (High) 101.         Treatment for the event included ibuprofen. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain, Pain in extremity, Vaccination site nodule, Vaccination site warmth
Clinical narrative: Pain radiates form right arm to hand; (arm) area is kind of warm; cannot move her arm as well as she used to (bending elbow and lifting arm); soreness in her arm; knot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (knot at the injection site), VACCINATION SITE WARMTH ((arm) area is kind of warm), LIMB DISCOMFORT (cannot move her arm as well as she used to (bending elbow and lifting arm)), PAIN IN EXTREMITY (soreness in her arm) and PAIN (Pain radiates form right arm to hand) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (Stable) since 2009. Concomitant products included LISINOPRIL from 12-Aug-2020 to an unknown date for Hypertension.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE NODULE (knot at the injection site) and PAIN IN EXTREMITY (soreness in her arm). On 07-Apr-2021, the patient experienced VACCINATION SITE WARMTH ((arm) area is kind of warm) and LIMB DISCOMFORT (cannot move her arm as well as she used to (bending elbow and lifting arm)). On 14-Apr-2021, the patient experienced PAIN (Pain radiates form right arm to hand). At the time of the report, VACCINATION SITE NODULE (knot at the injection site), VACCINATION SITE WARMTH ((arm) area is kind of warm), LIMB DISCOMFORT (cannot move her arm as well as she used to (bending elbow and lifting arm)), PAIN IN EXTREMITY (soreness in her arm) and PAIN (Pain radiates form right arm to hand) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient tried to massage his arm and heating for his symptoms. Patient weight 216 Patient race was black.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Added event,  Updated patient demographics relevant history, concomitant medication, outcome of the added event.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Sunburn, Vaccination site erythema
Clinical narrative: itches a little bit now and then; redness/It's a little red on her chest and back of her neck; large hot red spot on my arm/about the size of a baseball/increased in size down her arm; it's like a slight sunburn; This spontaneous case was reported by a consumer and describes the occurrence of SUNBURN (it's like a slight sunburn), PRURITUS (itches a little bit now and then), ERYTHEMA (redness/It's a little red on her chest and back of her neck) and VACCINATION SITE ERYTHEMA (large hot red spot on my arm/about the size of a baseball/increased in size down her arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 032M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SUNBURN (it's like a slight sunburn). On an unknown date, the patient experienced PRURITUS (itches a little bit now and then), ERYTHEMA (redness/It's a little red on her chest and back of her neck) and VACCINATION SITE ERYTHEMA (large hot red spot on my arm/about the size of a baseball/increased in size down her arm). At the time of the report, SUNBURN (it's like a slight sunburn), PRURITUS (itches a little bit now and then), ERYTHEMA (redness/It's a little red on her chest and back of her neck) and VACCINATION SITE ERYTHEMA (large hot red spot on my arm/about the size of a baseball/increased in size down her arm) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided. The action taken for mRNA-1273 was not applicable.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Under 18 years old vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years old vaccination) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years old vaccination). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years old vaccination) had resolved. Not Provided          Patient was schedule the HPV vaccine and she was given the Moderna COVID-19 vaccine. No concomitant information was reported. No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: headaches; fevers; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) and PYREXIA (fevers) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches) and PYREXIA (fevers). At the time of the report, HEADACHE (headaches) and PYREXIA (fevers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17-year-old patient received the 1st Moderna vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old patient received the 1st Moderna vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old patient received the 1st Moderna vaccine). On 11-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old patient received the 1st Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-075042, US-MODERNATX, INC.-MOD-2021-074958 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075042:Same reporter US-MODERNATX, INC.-MOD-2021-074958:Same reporter
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Headache, Nausea, Vomiting
Clinical narrative: Clammy feeling; nausea; Vomiting; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Clammy feeling), NAUSEA (nausea), VOMITING (Vomiting), HEADACHE (Headache) and CHILLS (Chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced COLD SWEAT (Clammy feeling), NAUSEA (nausea), VOMITING (Vomiting), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, COLD SWEAT (Clammy feeling), NAUSEA (nausea), VOMITING (Vomiting), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Eye disorder, Pain in extremity, Pyrexia
Clinical narrative: eye problems; slight sensation in the ears; sore arm; fever; This spontaneous case was reported by a patient and describes the occurrence of EYE DISORDER (eye problems), EAR DISCOMFORT (slight sensation in the ears), PAIN IN EXTREMITY (sore arm) and PYREXIA (fever) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CRATAEGUS LAEVIGATA, MAGNESIUM CITRATE, PLECTRANTHUS HADIENSIS, THEANINE, THEOBROMA CACAO (HIGH BLOOD PRESSURURE) and DICLOFENAC SODIUM (ANTI-INFLAMMATORY) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced EYE DISORDER (eye problems), EAR DISCOMFORT (slight sensation in the ears), PAIN IN EXTREMITY (sore arm) and PYREXIA (fever). At the time of the report, EYE DISORDER (eye problems), EAR DISCOMFORT (slight sensation in the ears), PAIN IN EXTREMITY (sore arm) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided by the reporter.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms for about 8 hours from first dose; This spontaneous case was reported by an other caregiver and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms for about 8 hours from first dose) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart valve disorders and Defibrillator/pacemaker insertion.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms for about 8 hours from first dose). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms for about 8 hours from first dose) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075163 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075163:dose 2
Age: 18.0
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received second dose two weeks before scheduled date; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose two weeks before scheduled date) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose two weeks before scheduled date). On 13-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose two weeks before scheduled date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.  The action taken with mRNA-1273 with the events was considered as not applicable
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Malaise
Clinical narrative: so sick; really bad reaction; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (so sick) and ADVERSE REACTION (really bad reaction) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced MALAISE (so sick) and ADVERSE REACTION (really bad reaction). At the time of the report, MALAISE (so sick) and ADVERSE REACTION (really bad reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication information was reported. Patient complained that they got "so sick" on 15Mar2021 from the first dose and described as having a "really bad reaction within 3 hours".   This case was linked to MOD21-072106 (E2B Linked Report).; Sender's Comments:  MOD21-072106:
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: very sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (very sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (very sick). At the time of the report, MALAISE (very sick) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Product contamination physical
Clinical narrative: Received Vaccine from a vial having black particles in it; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT CONTAMINATION PHYSICAL (Received Vaccine from a vial having black particles in it) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 13-Apr-2021, the patient experienced PRODUCT CONTAMINATION PHYSICAL (Received Vaccine from a vial having black particles in it). At the time of the report, PRODUCT CONTAMINATION PHYSICAL (Received Vaccine from a vial having black particles in it) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: rash/red hives; breaking out on both arms; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (rash/red hives) and RASH (breaking out on both arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced URTICARIA (rash/red hives) and RASH (breaking out on both arms). At the time of the report, URTICARIA (rash/red hives) and RASH (breaking out on both arms) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient confirmed that she is taking other medications; list not provided.  Treatment provided with alcohol on arms and washing with cold water.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (soreness of arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 007B21A and 010M20A) for COVID-19 immunization. No medical history reported. On Mar 10, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced  pain in extremity (soreness of arm). At the time of the report, pain in extremity (soreness of arm) resolved. No concomitant medications provided. Treatment medications unknown. The patient received both scheduled doses of mRNA-1273 prior to the event. The action taken with the drug in response to the event: not applicable. Most recent follow-up information incorporated: On May 4, 2021: Follow-up received on May 4, 2021, event outcome updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Vertigo
Clinical narrative: vertigo; felt exhausted; had a swollen lymph node under my left armpit; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), FATIGUE (felt exhausted) and LYMPHADENOPATHY (had a swollen lymph node under my left armpit) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced FATIGUE (felt exhausted) and LYMPHADENOPATHY (had a swollen lymph node under my left armpit). On 12-Apr-2021, the patient experienced VERTIGO (vertigo). On 05-Apr-2021, FATIGUE (felt exhausted) and LYMPHADENOPATHY (had a swollen lymph node under my left armpit) had resolved. At the time of the report, VERTIGO (vertigo) outcome was unknown.            No concomitant medication was provided by the reporter.  No treatment medication was provided by the reporter.   This case was linked to MOD-2021-075142 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of COVID-19 (COVID-19 symptoms nine days after the first vaccine/positive COVID-19 test) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 045A21A) for COVID-19 vaccination. No medical history reported. On Mar 19, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 28, 2021, patient experienced COVID-19 (COVID-19 symptoms nine days after the first vaccine/positive COVID-19 test). On Apr 10, 2021, COVID-19 (COVID-19 symptoms nine days after the first vaccine/positive COVID-19 test) resolved. Diagnostic results: On Mar 28, 2021, SARS-CoV-2 test: Positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.